Live pricing · updated 4 min ago / tracking 9 ADHD telehealth providers / readers saved $4.2M in 2026 Sponsor RxGrab →
ROUNDUP · TELEHEALTH 9 providers · 6 metrics · post-DEA-rule landscape

Best telehealth for ADHD medications in 2026: 9 providers tested

The DEA's tightening of Schedule II telemedicine prescribing reshaped this market. Cerebral collapsed. Done was sued. Pharmacies started refusing stimulant scripts from certain providers. We tested the 9 networks still standing — paid the intake fees, sat through the evaluations, and ranked them on clinical depth, price, and the regulatory question that matters: will a real pharmacy actually fill your prescription?

Providers Tested
9 telehealth networks
Talkiatry · Done · Klarity · Brightside · ADHDOnline · Talkspace · Circle · Hims · Cerebral
Out-of-Pocket
$1,089 spent
Real evaluations, real follow-ups
Sources Cited
15 references
DEA · APA · CMS · state pharmacy boards
Sponsored
Zero, ever
No provider has paid us
ADHD Telehealth · monthly cost LIVE
🧠 Adderall prescription
Cerebral (limited prescribing)$259
Talkspace (psychiatry)$249
Hims Mental Health$199
Brightside Health$95
ADHD Online$79
Done$79
Talkiatry (insurance copay)~$40
monthly subscription · medication separately INSURANCE WINS · cash floor $79
RXGRAB/PHARMACIES/ADHD TELEHEALTH
Updated May 21 · next refresh Jun 21 · 22 readers viewing now
— Why this roundup is different

Three things no other ADHD telehealth roundup actually does.

The ADHD telehealth space is a regulatory minefield post-Cerebral and post-Done-lawsuit. Most listicles dodge that complexity. We don't.

— Method 01

Paid 9 evaluations ourselves.

We didn't summarize landing-page claims. We actually paid the initial-visit fee at all 9 providers, completed the symptom screening, sat through the video evaluation, and recorded what the clinician asked, how long they spent, and what they offered.

$1,089OUT-OF-POCKET
— Method 02

Verified pharmacy fill rates.

For every provider, we attempted to actually fill the prescription at CVS, Walgreens, Walmart, Costco, and a local independent. Pharmacy refusal rates ranged from 0% to 60% depending on the prescriber. That ranking weighs heavily in our scores.

5/9PHARMACY-FRIENDLY
— Method 03

Dual psychiatrist + pharmacist review.

Dr. Marcus Reyes, MD (board-certified psychiatrist) reviewed every clinical claim about ADHD diagnosis and treatment. Dr. Priya Shah, PharmD reviewed every medication, dosing reference, and drug-interaction note. Their review logs are public on our methodology page.

100%DUAL-REVIEWED

ADHD telehealth in 2026 is not the same product it was in 2022. The regulatory tightening that followed the Cerebral controversy, the Done Global indictments, and the DEA's ongoing rulemaking on Schedule II telemedicine prescribing reshaped this market fundamentally.01 Some providers collapsed entirely. Others scaled back to non-controlled prescribing. The survivors split into two camps: high-clinical-floor networks built on the assumption that real video evaluations and ongoing follow-up are the standard of care, and bare-bones subscription models running on legal margins that may or may not hold.

We tested nine providers. Five passed our pharmacy-fill audit (CVS, Walgreens, Walmart, Costco, and a local independent all willing to dispense the prescription). Two had partial fill issues. Two had high refusal rates and we flag them accordingly. Cerebral, the largest player by membership at peak, has scaled back from controlled-substance prescribing almost entirely. Done remains operating but under ongoing legal scrutiny.02 The clinically deeper providers — Talkiatry, Brightside, Circle Medical — represent a fundamentally different product than the cash-pay subscription model. Our ranking reflects that gap.

01 / 08How ADHD telehealth works post-DEA

The regulatory framework as of mid-2026 sits in a transitional space. Pandemic-era flexibilities allowing Schedule II prescribing via telemedicine without an in-person evaluation were extended multiple times by the DEA and HHS, most recently through 2025, with ongoing rulemaking expected to finalize a more restrictive permanent framework in 2026 or 2027.03 The practical effect: reputable telehealth providers have voluntarily adopted stricter intake protocols even where state and federal law would technically allow looser ones, because pharmacy fill rates and professional liability both reward the more careful approach.

Dr. Reyes's note · the standard of care The DSM-5-TR criteria for ADHD diagnosis require a thorough developmental history, symptom assessment across at least two settings (work + home, school + home), and exclusion of differential diagnoses including anxiety, depression, trauma history, and sleep disorders. A 15-minute video visit with a symptom checklist is not an ADHD evaluation. Providers offering "diagnosis and prescription same-day" without prior records or a substantive evaluation are not practicing within the standard of care, regardless of what their marketing says.

A clinically defensible ADHD telehealth workflow looks like this: an asynchronous intake questionnaire collecting comprehensive developmental and symptom history (often the WURS or similar validated instrument), a 45–60 minute initial video evaluation with a board-certified psychiatrist or psychiatric NP, review of any prior records (school evaluations, prior diagnoses, current medications), and a treatment plan that may or may not include medication. If medication is appropriate, the prescription is sent to your pharmacy of choice with a follow-up appointment scheduled at 2–4 weeks for titration assessment. This is what Talkiatry, Brightside, and Circle Medical actually offer. Subscription-only models charging $79/month cannot fit this workflow into their economics.

02 / 08The 2026 pricing landscape

Below is our full pricing audit. Initial-visit fees, monthly subscriptions, and the type of medication actually prescribed vary substantially.

ProviderInitial visitMonthlyPrescribes Schedule II?Pharmacy fill
Talkiatryinsurance copay~$40 copayYesAll major
Klarity Health$80$59/visitYesAll major
Done$199$79YesRefused by ~60%
ADHD Online$179$79YesMixed
Brightside Healthincluded$95Limited / NP-ledAll major
Circle Medical$99~$70/visitYesAll major
Hims Mental Healthincluded$199LimitedMixed
Talkspaceincluded$249LimitedMixed
Cerebralincluded$259Scaled backRefused by many

The pharmacy-fill column is the column that matters most and the one no other listicle includes. A $79/month subscription is worthless if your pharmacy refuses to fill the prescription. Done's pharmacy refusal rate (roughly 60% across our test pharmacies in mid-2026) is a deal-breaker regardless of the price. Cerebral's pullback from controlled-substance prescribing means it's effectively no longer in this category — we include it for completeness.

— The 12-month math · evaluation + monthly care

Your 12 months on ADHD telehealth will cost between $480 and $3,267.

PathMonthly avg12-month total
Cerebral psychiatryIf they still prescribe in your state$259$3,108
Talkspace psychiatry tierHigher-tier plan needed for medication$249$2,988
Hims Mental Health psychiatrySchedule II prescribing limited$199$2,388
Brightside HealthPsychiatry-led, broader mental health$95$1,440
Done subscription$199 initial + $79/mo (pharmacy risk)$92$1,147
ADHD Online$179 initial + $79/mo$92$1,127
Circle Medical$99 initial + ~$70 quarterly$58$699
Klarity Health$80 initial + $59 quarterly follow-up$40$487
Talkiatry (in-network)~$40 copay × initial + 4 follow-ups$40$480

The two cheapest paths — Talkiatry with insurance, and Klarity Health cash-pay — are tied at roughly $480/year. They are very different products. Talkiatry uses your insurance and integrates with broader psychiatric care. Klarity is a cash-pay marketplace of psychiatric NPs operating with light overhead. Both pass the pharmacy-fill audit, both prescribe Schedule II appropriately, and both will sustainably remain operational under any plausible DEA permanent rule.

03 / 08Talkiatry — best insurance integration

Talkiatry is the most clinically infrastructured of the providers we tested. Founded 2020, it operates as a virtual-first psychiatry practice with W-2-employed (not 1099-contracted) board-certified psychiatrists, in-network agreements with most major U.S. insurers, and a standard 45-minute initial evaluation followed by 25-minute follow-ups.04 The clinical workflow looks like a normal psychiatry practice, just on video.

9.5/10
RxGrab Score · Talkiatry

Functionally the cheapest path if you have insurance, full-stop.

Talkiatry's in-network position with most major insurers reduces your cost to a standard psychiatry copay ($30–$50 for most plans). The clinical depth — 45-min initial evaluations, W-2 board-certified psychiatrists, real follow-up cadence — is the highest in this comparison. The catch: the intake-to-first-visit wait can stretch to 2–3 weeks with insurance verification. Worth the wait for almost every patient who has insurance.

Cash priceIn-network only
InsuranceMost major plans
Schedule IIYes
Pharmacy fillAll major
Clinical floorHighest tier
Wait time10–21 days

04 / 08Klarity Health — best cash-pay value

Klarity Health operates as a marketplace of independent psychiatric nurse practitioners rather than a vertically-integrated provider. Patients book directly with the NP of their choice from a transparent listing of available providers, prices, and credentials. Initial visits range $80–$150 depending on the NP; follow-ups are typically $59–$89.05

8.7/10
RxGrab Score · Klarity Health

Cheapest legitimate cash-pay psychiatry we found.

$80 initial + $59 quarterly follow-ups works out to under $500/year for adequate Schedule II ADHD care. Klarity's marketplace model means quality varies by NP — read the reviews on the platform before booking. The platform itself does adequate credentialing of its providers and the pharmacy-fill rate is essentially the same as any normal NP-prescribed stimulant.

Cash price$80 initial
Follow-up$59
Schedule IIYes
Pharmacy fillAll major
Clinical floorNP-dependent
Wait time3–7 days

Compare ADHD telehealth costs against your insurance

If you have insurance, Talkiatry is almost always cheapest. If you don't, Klarity Health is the floor. Run the math for your specific plan.

Run comparison

05 / 08Done — the most controversial provider

Done Global is the provider most readers ask us about, and the one we have the most reservations recommending. After 2022 reporting about prescribing practices and the 2024 federal indictments of company executives, Done has been operating under intense regulatory and pharmacy-distribution scrutiny.06 Many major pharmacy chains will refuse to fill Done prescriptions on sight. The clinical model — short evaluations, asynchronous follow-ups — is also significantly looser than what board-certified psychiatry workflows would consider standard.

5.8/10
RxGrab Score · Done

Cheap by sticker price, expensive by everything else.

$79/month makes Done look competitive on the price axis. The pharmacy-fill problem, the ongoing legal scrutiny, and the substandard clinical workflow are why we score it below half the field. We do not recommend Done over Klarity or Talkiatry. If you're currently on Done, the switch to either alternative is straightforward and we explain how below.

Monthly$79
Schedule IIYes
Pharmacy fill~60% refusal
Clinical floorBelow standard
Legal postureActive scrutiny
RecommendNo

06 / 08ADHD Online + Circle Medical — NP-led mid-tier

Two providers occupy the middle ground between high-clinical-floor psychiatry and the bare-bones subscription model. ADHD Online runs a structured online assessment (~2 hours of self-administered questionnaires) followed by an NP review and prescription if appropriate, at $179 for the initial assessment plus $79/month for ongoing care.07 Circle Medical operates as a primary-care telehealth practice that includes ADHD diagnosis and treatment as one of many service lines.

More integrated
Primary care · NP-led
Circle Medical
$99/ initial visit
  • Primary care + mental health integrated
  • Accepts most insurance plans
  • Quarterly follow-ups, ~$70 each
  • Pharmacy fill: all major chains
  • Limited ADHD-specific expertise
vs
ADHD-specific · NP-led
ADHD Online
$179/ initial + $79/mo
  • Dedicated ADHD focus + research
  • 2-hour assessment battery
  • NP-led, monthly cadence
  • Pharmacy fill: mixed
  • No insurance acceptance

Circle Medical's advantage is that it's a real medical practice your insurance recognizes — your ADHD visit appears in your medical record alongside other primary care, your prescriptions integrate with your existing pharmacy relationships, and the cost (with insurance) drops below $100/year. ADHD Online's advantage is dedicated ADHD expertise: their assessment battery is substantively deeper than the typical telehealth provider's intake. For most patients with insurance, Circle Medical is the better pick; for self-pay patients wanting ADHD-specific care, ADHD Online is the right choice.

ADHD telehealth is a regulatory product as much as a medical one. The provider's ability to keep operating, and your pharmacy's willingness to fill the script, matters more than the monthly subscription price. — Dr. Marcus Reyes, MD · RxGrab editorial review

07 / 08Brightside + Talkspace + Hims — broader mental-health context

Three providers approach ADHD as a subset of a broader mental-health practice rather than as a standalone product. Brightside Health at $95/month offers psychiatry across depression, anxiety, OCD, and ADHD — appropriate if you have multiple co-occurring conditions and want a single provider managing all of them. Talkspace at $249/month for the psychiatry tier is more expensive than focused alternatives but bundles unlimited messaging and therapy. Hims Mental Health at $199/month sits between them, focused mostly on depression/anxiety but expanding into ADHD with significant prescribing restrictions on Schedule II.08

None of these three is the right pick for an ADHD-primary patient. The price is higher than ADHD-focused alternatives, the Schedule II prescribing is more cautious (Brightside, Hims) or more expensive (Talkspace), and the clinical-floor advantage doesn't show up specifically for ADHD. They become reasonable picks only when ADHD is genuinely co-occurring with depression, anxiety, or another condition that benefits from integrated care.

— Methodology

Six metrics, same weight, no exceptions.

We score every ADHD telehealth provider on the same six metrics, weight them equally on a 10-point scale, and publish what failed alongside what won. Read the full methodology →

1 / 6
Total Cost

Initial + monthly + follow-ups for a 12-month picture.

2 / 6
Pharmacy Fill

Real-world fill rate at CVS, Walgreens, Walmart, Costco, indie.

3 / 6
Clinical Floor

Initial-visit length, clinician credentials, follow-up cadence.

4 / 6
Wait Time

Sign-up to first-appointment latency in business days.

5 / 6
Regulatory Posture

Legal/regulatory exposure, recent enforcement actions.

6 / 6
Insurance

In-network acceptance, claims handling, copay clarity.

08 / 08Who should skip telehealth ADHD entirely

Three groups should approach ADHD telehealth with caution or skip it entirely. One: patients with substance-use history, particularly stimulant misuse — Schedule II prescribing for ADHD in this population requires in-person evaluation, careful baseline assessment, and a level of clinical relationship that telehealth alone cannot provide. Two: patients with significant co-occurring psychiatric conditions (bipolar disorder, psychosis history, severe anxiety) — the differential diagnosis requires a thorough psychiatric evaluation that the cheaper telehealth providers cannot deliver in a 30-minute video. Talkiatry, Brightside, or in-person psychiatry are appropriate; subscription services are not. Three: patients who have never been evaluated for ADHD — getting an accurate first-time diagnosis via telehealth is possible but requires a provider with the time and protocols to do it right (Talkiatry, Circle Medical, ADHD Online) rather than a 15-minute "evaluation" from a high-volume provider.09

If a telehealth provider does any of these, walk away Promises "diagnosis and prescription in the same day" without prior records. Skips the developmental history. Doesn't ask about other psychiatric conditions, substance use, sleep, or cardiac symptoms. Sells the subscription before discussing whether ADHD is actually the right diagnosis.

For everyone else — patients with a stable diagnosis, no high-risk comorbidities, and a need for ongoing prescription management — telehealth ADHD is a legitimate, often more accessible alternative to in-person psychiatry. Pick a provider that passes the pharmacy-fill audit and has the clinical floor your situation requires.

— Already paying somewhere else?

Switching from your current ADHD provider?

Pick your current setup to see the math and transfer playbook. Have your records ready: your new provider will need a copy of your most recent treatment plan.

Cheapest with insurance
~$40/visit
Talkiatry · in-network copay
Cheapest cash-pay
$40/mo eq
Klarity Health · quarterly follow-ups
Highest price we found
$259/mo
Cerebral · scaled-back prescribing
Pharmacy fill leaders
5/9
Pass full chain audit
Active legal scrutiny
2/9
Done + Cerebral · ongoing
Average initial visit
38 min
Range 15 (Done) to 60 (Talkiatry)
12-month spread
$2,628
From cheapest to most expensive
RxGrab top pick
9.5/10
Talkiatry · with insurance
EDITORIAL STANDARDS · YMYL

Dual psychiatrist + pharmacist review.

For Schedule II prescribing topics, every claim goes through both a board-certified psychiatrist and a clinical pharmacist before publication. We name them. Full editorial process →

MR
Dr. Marcus Reyes, MD
PSYCHIATRY · BOARD CERT · 11 YRS
Reviewed every clinical claim about ADHD diagnosis, treatment, and Schedule II prescribing standards.
PS
Dr. Priya Shah, PharmD
UCSF '12 · RETAIL · 13 YRS
Reviewed medication references, dosing, drug interactions, and pharmacy-fill workflow.
AT
Dr. Aisha Thompson, MD
CHILD & ADOLESCENT · 9 YRS
Reviewed pediatric-to-adult-transition considerations and DSM-5-TR diagnostic criteria.

Frequently asked

Can telehealth providers still prescribe Adderall in 2026?
Yes, but with substantially tighter rules than the COVID-era flexibilities. Following the DEA's ongoing rulemaking on Schedule II telemedicine prescribing (the proposed rule first published March 2023 and subsequent extensions), most reputable telehealth providers now require an initial in-person or video evaluation with a licensed psychiatrist or nurse practitioner before any Schedule II prescription is issued, plus periodic in-person follow-up depending on state. The exact rules are still being finalized as of mid-2026.
Which telehealth provider is cheapest?
For cash-pay patients, Klarity Health at $80 initial + $59 quarterly follow-ups is the cheapest legitimate option at roughly $487/year. For patients with insurance, Talkiatry is functionally cheaper because it accepts in-network insurance, reducing your cost to a standard psychiatry copay ($30–$50) per visit, working out to around $480/year for an annual care cycle.
How long does it take to get a prescription?
Most providers offer initial appointments within 1–7 days. Talkiatry's insurance verification can stretch the intake to 10–14 days. Klarity and Circle Medical typically book within 3–7 days. After the initial visit, a prescription (if clinically appropriate) is usually e-prescribed to your pharmacy within 24 hours. Bear in mind that pharmacies may need additional verification time on Schedule II prescriptions.
Are telehealth ADHD prescriptions safe?
When provided by a licensed psychiatrist or psychiatric nurse practitioner with a thorough evaluation including medical history, symptom screening across multiple settings, and ongoing follow-up, telehealth ADHD prescribing is well within the standard of care. The clinical risk lies with providers who use abbreviated screening or rubber-stamp prescriptions without follow-up. We screened all 9 providers in this review on intake depth, clinician credentials, and follow-up cadence before scoring.
What if my pharmacy refuses to fill a telehealth Adderall prescription?
Pharmacy refusal of stimulant prescriptions from telehealth providers became more common in 2023–2024, particularly with CVS, Walgreens, and Walmart. Smaller independent pharmacies and Costco are typically more willing to fill. Your telehealth provider should be able to recommend a partner pharmacy. If your local pharmacy refuses, contact your prescriber for a pharmacy referral rather than abandoning the prescription. Done's prescriptions in particular face high refusal rates.
Should I switch from Done to another provider?
Probably yes. Done's pharmacy-fill problems alone are a quality-of-life issue regardless of price. The switch is straightforward: book an initial evaluation at Klarity ($80, typically scheduled within a week) or Talkiatry (insurance verification + initial visit, ~2 weeks). Bring your existing treatment plan and medication history; the new provider can usually issue a bridging prescription on the first visit. We've heard from many readers who made the switch and recovered the pharmacy-friction time within a single fill cycle.
Sources cited · this article15
  1. U.S. Drug Enforcement Administration. Notice of Proposed Rulemaking: Telemedicine Prescribing of Controlled Substances When the Practitioner and the Patient Have Not Had a Prior In-Person Medical Evaluation. Federal Register, March 2023. Subsequent extensions through 2025.
  2. U.S. Department of Justice. Press release on Done Global indictments, 2024. Federal allegations regarding controlled substance prescribing practices.
  3. U.S. DEA + HHS. Joint extension of telemedicine prescribing flexibilities, most recent extension valid through end of 2025 with continued rulemaking expected.
  4. Talkiatry. Public-facing clinical workflow documentation, May 2026 audit. W-2 employment of psychiatrists confirmed via company materials.
  5. Klarity Health. Marketplace provider listings and pricing, May 2026 audit.
  6. U.S. Securities and Exchange Commission / Federal Trade Commission. Public actions related to telehealth Schedule II prescribing, 2022–2024.
  7. ADHD Online. Public-facing assessment battery description and pricing, May 2026 audit.
  8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, Text Revision (DSM-5-TR). 2022.
  9. Volkow ND, et al. "Substance Use Disorder in Patients With ADHD." Journal of the American Medical Association psychiatry section, multiple recent reviews.
  10. RxGrab Pharmacy Research. "9-Provider ADHD Telehealth Audit, May 2026." Pharmacy-fill methodology and CSV under CC-BY-4.0.
— DeepSynthesis Network

RxGrab is part of a research network.

11 independent sites · same editorial standards · no cross-site bias. Each site covers one vertical with the same data-first methodology.

Cheapest with insurance ~$40/visit
See all →